BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16735251)

  • 1. Tandem mass spectrometry program implementation challenges for state newborn screening programs: national survey of barriers and issues.
    Feuchtbaum L; Faulkner L; Verghese S
    Pediatrics; 2006 May; 117(5 Pt 2):S253-60. PubMed ID: 16735251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
    Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories.
    Hannon H; Lim T; Adam B; Therrell B
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():121-6. PubMed ID: 15906714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primer on expanded newborn screening by tandem mass spectrometry.
    McCandless SE
    Prim Care; 2004 Sep; 31(3):583-604, ix-x. PubMed ID: 15331249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.
    Garg U; Dasouki M
    Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing state newborn screening programs: sources and uses of funds.
    Johnson K; Lloyd-Puryear MA; Mann MY; Ramos LR; Therrell BL
    Pediatrics; 2006 May; 117(5 Pt 2):S270-9. PubMed ID: 16735253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practices and perceptions of long-term follow-up among state newborn screening programs.
    Hoff T; Hoyt A
    Pediatrics; 2006 Jun; 117(6):1922-9. PubMed ID: 16740832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
    Wilfond BS; Gollust SE
    J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National evaluation of US newborn screening system components.
    Therrell BL; Hannon WH
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):236-45. PubMed ID: 17183567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in establishing and maintaining newborn screening systems.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():6-12. PubMed ID: 15906685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical problems with neonatal screening.
    Orzalesi M; Danhaive O
    Ann Ist Super Sanita; 2009; 45(3):325-30. PubMed ID: 19861738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the quality and efficiency of newborn screening programs through the use of health information technology.
    Downing GJ; Zuckerman AE; Coon C; Lloyd-Puryear MA
    Semin Perinatol; 2010 Apr; 34(2):156-62. PubMed ID: 20207265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the communication practices between state newborn screening programs and the medical home.
    Kim S; Lloyd-Puryear MA; Tonniges TF
    Pediatrics; 2003 Feb; 111(2):E120-6. PubMed ID: 12563084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of newborn screening programs in the United States.
    Therrell BL; Johnson A; Williams D
    Pediatrics; 2006 May; 117(5 Pt 2):S212-52. PubMed ID: 16735250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent.
    Liebl B; Nennstiel-Ratzel U; von Kries R; Fingerhut R; Olgemöller B; Zapf A; Roscher AA
    Prev Med; 2002 Feb; 34(2):127-31. PubMed ID: 11817906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.